HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fredrik Wermeling Selected Research

Serum Response Factor

1/2020An intronic deletion in megakaryoblastic leukemia 1 is associated with hyperproliferation of B cells in triplets with Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fredrik Wermeling Research Topics

Disease

10Autoimmune Diseases (Autoimmune Disease)
01/2022 - 10/2007
8Inflammation (Inflammations)
11/2020 - 12/2008
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 10/2007
3Neoplasms (Cancer)
01/2022 - 04/2012
2Rheumatoid Arthritis
12/2021 - 01/2018
2Atherosclerosis
01/2019 - 06/2011
2Infections
01/2016 - 04/2012
1Myositis (Idiopathic Inflammatory Myopathies)
01/2021
1Human Influenza (Influenza)
01/2021
1Leukemia
01/2020
1Aneurysm (Aneurysms)
01/2019
1Hyperplasia
01/2019
1Hypersensitivity (Allergy)
01/2019
1Pain (Aches)
01/2019
1Colitis
04/2016
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2016
1Neuroblastoma
01/2016
1Lymphoma (Lymphomas)
01/2016
1Cystic Fibrosis (Mucoviscidosis)
01/2014
1Pneumonia (Pneumonitis)
01/2014
1type 1 Autoimmune polyendocrinopathy syndrome
05/2013
1Chronic Mucocutaneous Candidiasis
05/2013
1Arthritis (Polyarthritis)
06/2011
1Cardiovascular Diseases (Cardiovascular Disease)
06/2011
1Disease Progression
10/2007

Drug/Important Bio-Agent (IBA)

7AutoantibodiesIBA
01/2021 - 10/2007
4AutoantigensIBA
01/2018 - 10/2007
3Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2016
3Interleukin-4 (Interleukin 4)IBA
11/2020 - 06/2011
3AntibodiesIBA
01/2019 - 04/2012
3Immunoglobulin G (IgG)IBA
01/2019 - 04/2012
3CytokinesIBA
01/2014 - 06/2011
3Intravenous Immunoglobulins (IVIG)FDA Link
08/2013 - 12/2008
2Pharmaceutical PreparationsIBA
01/2022 - 08/2013
2AntigensIBA
12/2021 - 01/2019
2Interleukin-2 (IL2)IBA
01/2021 - 01/2016
2Antigen-Antibody Complex (Immune Complex)IBA
01/2019 - 04/2012
2LigandsIBA
08/2013 - 06/2011
2Scavenger Receptors (Scavenger Receptor)IBA
06/2011 - 10/2007
1A-Form DNA (A-DNA)IBA
01/2022
1TenascinIBA
12/2021
1serum P-component (CIt)IBA
12/2021
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2021
1Peptides (Polypeptides)IBA
01/2021
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
11/2020
1Interleukin-13IBA
11/2020
1Serum Response FactorIBA
01/2020
1Cartilage Oligomeric Matrix ProteinIBA
01/2019
1Pancreatic Elastase (Elastase)IBA
01/2019
1Fc Receptors (Fc Receptor)IBA
01/2019
1Collagen Type II (Type II Collagen)IBA
01/2019
1Anti-Citrullinated Protein AntibodiesIBA
01/2018
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
01/2018
1A-factor (Streptomyces)IBA
04/2016
1Wiskott-Aldrich Syndrome ProteinIBA
01/2016
1ProfilIBA
01/2014
1CeramidesIBA
01/2014
1STAT6 Transcription FactorIBA
08/2013
1CystatinsIBA
05/2013
1Polysaccharides (Glycans)IBA
04/2012
1Interleukin-33IBA
06/2011
1oxidized low density lipoproteinIBA
06/2011
1Biomarkers (Surrogate Marker)IBA
07/2010

Therapy/Procedure

1Therapeutics
01/2019